BRC News

UCLH was the top recruiter of patients to studies on the NIHR portfolio last year in the North Thames area – the NIHR region which includes 23 NHS Trusts and 20 Clinical Commissioning Groups in parts of London, Essex, Bedfordshire and Hertfordshire.

Breathing aids developed by engineers at UCL, UCLH and the Mercedes F1 team have been delivered to 40 NHS hospitals.

Pioneering research suggests that currently the public should not fear contracting Covid-19 from hospital staff, who appear to be at low risk of infection by patients.

Trial to see if a drug suppresses overactive immune system response.

UCLH now has 24 active Covid-19 research studies – up from nine at the beginning of the month – with another 9 under consideration or being set up.

Doctors are used to ordering tests for patients – such as bloods or MRI scans – but they will now test out a platform where they can order the analysis of large-scale data relevant to an individual patient and treatment decision they face, with results returned within clinical timescales.

The study is looking at how children with immune problems or on immune-suppressant drugs will respond to Covid-19.

Some people seem to experience a highly overactive immune response that may be putting them at risk.

A study which quickly identifies the cause of a patient’s pneumonia is being re-purposed to help in Covid-19.

The ultimate aim is to contribute to the development of a vaccine.

UCLH staff are part of a study looking at rates of Covid-19 infection among healthcare workers.

Patients and UCLH representatives met in the latest of our remote PPI sessions.

UCLH is taking part in two global clinical trials of an antiviral drug for COVID-19.

The trial has an ‘adaptive’ design where new therapies can be added to the study over time.

The ISARIC-4C study aims to provide an agile research response to infectious disease outbreaks.